tradingkey.logo

Haleon PLC

HLN
查看详细走势图
9.520USD
-0.070-0.73%
收盘 12/12, 16:00美东报价延迟15分钟
85.53B总市值
38.90市盈率 TTM

Haleon PLC

9.520
-0.070-0.73%
盘中分时
1分
30分
1小时
日k
周k
月k
日k

今天

-0.73%

5天

0.00%

1月

-3.84%

6月

-12.42%

今年开始到现在

-0.21%

1年

-2.46%

查看详细走势图

TradingKey Haleon PLC股票评分

单位: USD 更新时间: 2025-12-12

操作建议

Haleon PLC当前公司基本面数据相对健康,增长潜力很大。当前估值合理,在药品行业排名72/159位。机构持股占比非常高,近一月多位分析师给出公司评级为买入。最高目标价10.58。中期看,股价处于平稳状态。近一个月,市场表现一般,但公司基本面和技术面得分较高。目前股价在压力位和支撑位之间,可以做区间波段操作。

Haleon PLC评分

相关信息

行业排名
72 / 159
全市场排名
182 / 4592
所属行业
药品

压力支撑

由于公司未披露,未能获取相关数据

多维评测

本期评分
上期评分

分析师目标

根据 4 位分析师
买入
评级
10.579
目标均价
+12.54%
涨幅空间
数据免责声明:分析师评级与目标价由LSEG提供,仅供参考,不应当作投资建议

Haleon PLC亮点

亮点风险
Haleon plc is a consumer healthcare company. The Company’s product portfolio spans six major categories, including oral health, vitamins, minerals and supplements (VMS), pain relief, respiratory health, digestive health and therapeutic skin health and other. The Company’s geographical segments include North America, Europe, Middle East, Africa, and Latin America (EMEA) & LatAm, and Asia Pacific (APAC). Its respiratory health brands offer product solutions for a range of respiratory issues, including cold and flu, nasal congestion, coughs, and allergies. The Company’s oral health brands include Sensodyne, Polident, and Parodontax. Its VMS brands include Centrum, Emergen-C, and Caltrate. Its respiratory brands include Otrivin, Theraflu, Flonase, Contac, and Beechams. Its pain relief brands include Voltaren, Panadol, and Advil. Its digestive health brands include TUMS, ENO, and Benefiber. Its therapeutic skin health brands include Fenistil, Zovirax, and Bactroban.
利润高增长
公司净利润处于行业前列,最新年度总收入8.92B美元
高分红
公司属于高分红公司,最新股息支付率41.40%
估值低估
公司最新PE估值38.90,处于3年历史低位
机构减仓
最新机构持股570.14M股,环比减少2.78%
默里·斯塔尔持仓
明星投资者默里·斯塔尔持仓,最新持仓市值14.08K
活跃度降低
近期活跃度降低,过去20天平均换手率0.10

Haleon PLC新闻

即将为您带来更多新闻,敬请期待。。。

财务指标

每股收益

由于公司未披露,未能获取相关数据

营业总收入

由于公司未披露,未能获取相关数据

Haleon PLC简介

Haleon plc is a consumer healthcare company. The Company’s product portfolio spans six major categories, including oral health, vitamins, minerals and supplements (VMS), pain relief, respiratory health, digestive health and therapeutic skin health and other. The Company’s geographical segments include North America, Europe, Middle East, Africa, and Latin America (EMEA) & LatAm, and Asia Pacific (APAC). Its respiratory health brands offer product solutions for a range of respiratory issues, including cold and flu, nasal congestion, coughs, and allergies. The Company’s oral health brands include Sensodyne, Polident, and Parodontax. Its VMS brands include Centrum, Emergen-C, and Caltrate. Its respiratory brands include Otrivin, Theraflu, Flonase, Contac, and Beechams. Its pain relief brands include Voltaren, Panadol, and Advil. Its digestive health brands include TUMS, ENO, and Benefiber. Its therapeutic skin health brands include Fenistil, Zovirax, and Bactroban.
公司代码HLN
公司Haleon PLC
CEOMcnamara (Brian)
网址https://www.haleon.com/

常见问题

Haleon PLC(HLN)的当前股价是多少?

Haleon PLC(HLN)的当前股价是 9.520。

Haleon PLC的股票代码是什么?

Haleon PLC的股票代码是HLN。

Haleon PLC股票的52周最高点是多少?

Haleon PLC股票的52周最高点是11.420。

Haleon PLC股票的52周最低点是多少?

Haleon PLC股票的52周最低点是8.710。

Haleon PLC的市值是多少?

Haleon PLC的市值是85.53B。

Haleon PLC的净利润是多少?

Haleon PLC的净利润为1.44B。

现在Haleon PLC(HLN)的股票是买入、持有还是卖出?

根据分析师评级,Haleon PLC(HLN)的总体评级为买入,目标价格为10.579。

Haleon PLC(HLN)股票的每股收益(EPS TTM)是多少

Haleon PLC(HLN)股票的每股收益(EPS TTM)是0.245。
KeyAI